Immunogenicity of Constrained Monoclonal Antibody A32-Human Immunodeficiency Virus (HIV) Env gp120 Complexes Compared to That of Recombinant HIV Type 1 gp120 Envelope Glycoproteins

One strategy for the generation of broadly reactive neutralizing antibodies (NA) against human immunodeficiency virus type 1 (HIV-1) primary isolates is to use immunogens that have constrained HIV-1 envelope gp120 conformations reflective of triggered envelope on the surface of virions. A major chan...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Liao, Hua-Xin, Alam, S. Munir, Mascola, John R., Robinson, James, Ma, Benjiang, Montefiori, David C., Rhein, Maria, Sutherland, Laura L., Scearce, Richard, Haynes, Barton F.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2004
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC400342/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15113908/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.10.5270-5278.2004
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!